S-nitrosylation-mediated Redox Transcriptional Switch Modulates Neurogenesis and Neuronal Cell Death.
Shu-ichi Okamoto,Tomohiro Nakamura,Piotr Cieplak,Shing Fai Chan,Evgenia Kalashnikova,Lujian Liao,Sofiyan Saleem,Xuemei Han,Arjay Clemente,Anthony Nutter,Sam Sances,Christopher Brechtel,Daniel Haus,Florian Haun,Sara Sanz-Blasco,Xiayu Huang,Hao Li,Jeffrey D. Zaremba,Jiankun Cui,Zezong Gu,Rana Nikzad,Anne Harrop,Scott R. McKercher,Adam Godzik,John R. Yates,Stuart A. Lipton
DOI: https://doi.org/10.1016/j.celrep.2014.06.005
IF: 8.8
2014-01-01
Cell Reports
Abstract:Redox-mediated posttranslational modifications represent a molecular switch that controls major mechanisms of cell function. Nitric oxide (NO) can mediate redox reactions via S-nitrosylation, representing transfer of an NO group to a critical protein thiol. NO is known to modulate neurogenesis and neuronal survival in various brain regions in disparate neurodegenerative conditions. However, a unifying molecular mechanism linking these phenomena remains unknown. Here, we report that S-nitrosylation of myocyte enhancer factor 2 (MEF2) transcription factors acts as a redox switch to inhibit both neurogenesis and neuronal survival. Structure-based analysis reveals that MEF2 dimerization creates a pocket, facilitating S-nitrosylation at an evolutionally conserved cysteine residue in the DNA binding domain. S-Nitrosylation disrupts MEF2-DNA binding and transcriptional activity, leading to impaired neurogenesis and survival in vitro and in vivo. Our data define a molecular switch whereby redox-mediated posttranslational modification controls both neurogenesis and neurodegeneration via a single transcriptional signaling cascade.